About Canopy Biosciences
Canopy Biosciences is a company based in St. Louis (United States) founded in 2016 was acquired by Bruker in September 2020.. Canopy Biosciences has raised $4.48 million across 4 funding rounds from investors including Bruker, Ampersand Capital Partners and Kingdom Capital. Canopy Biosciences has completed 2 acquisitions, including Core Diagnostics and ZELLKRAFTWERK. Canopy Biosciences offers products and services including CellScape Instrument, Assay Kits, and CRO Services. Canopy Biosciences operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
- Headquarter St. Louis, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.48 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Bruker
& 7 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Core Diagnostics
& 1 more
-
Acquired by
Bruker
(Sep 11, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Canopy Biosciences
Canopy Biosciences offers a comprehensive portfolio of products and services, including CellScape Instrument, Assay Kits, and CRO Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables high-plex biomarker imaging and spatial quantification for research.
Supports spatial biology experiments with essential consumables and kits.
Offers end-to-end single-cell and RNA sequencing solutions for analysis.
Unlock access to complete
Funding Insights of Canopy Biosciences
Canopy Biosciences has successfully raised a total of $4.48M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(31 Jul 2017)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2019 | Amount | Series A - Canopy Biosciences | Valuation | Ampersand Capital |
|
| May, 2018 | Amount | Series A - Canopy Biosciences | Valuation | Kingdom Capital , BioGenerator | |
| Jan, 2018 | Amount | Seed - Canopy Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Canopy Biosciences
Canopy Biosciences has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Bruker, Ampersand Capital Partners and Kingdom Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Tech companies focused VC firm operating across Missouri
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Canopy Biosciences
Canopy Biosciences has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Core Diagnostics and ZELLKRAFTWERK. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biomarker analysis and translational support services are provided in diagnostics.
|
2014 | ||||
|
Developer of chip cytometry technology
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Canopy Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Canopy Biosciences Comparisons
Competitors of Canopy Biosciences
Canopy Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery and preclinical development services
|
|
| domain | founded_year | HQ Location |
Provider of laboratory tests for physicians
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| domain | founded_year | HQ Location |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
|
|
| domain | founded_year | HQ Location |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Canopy Biosciences
Frequently Asked Questions about Canopy Biosciences
When was Canopy Biosciences founded?
Canopy Biosciences was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is Canopy Biosciences located?
Canopy Biosciences is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Is Canopy Biosciences a funded company?
Canopy Biosciences is a funded company, having raised a total of $4.48M across 4 funding rounds to date. The company's 1st funding round was a Seed of $2.08M, raised on Jul 31, 2017.
What does Canopy Biosciences do?
Canopy Biosciences provides cell line engineering service based on the CRISPR-Cas9 system. They offer the following services tune gene expression from 100 to complete knockout, model ranges of gene expression reflecting diversity in patient populations, control endogenous gene expressioneliminate artifacts from ectopic expression, and knockdown essential genes where knockout would result in lethality.
Who are the top competitors of Canopy Biosciences?
Canopy Biosciences's top competitors include LabCorp, Charles River Laboratories and Cytel.
What products or services does Canopy Biosciences offer?
Canopy Biosciences offers CellScape Instrument, Assay Kits, and CRO Services.
How many acquisitions has Canopy Biosciences made?
Canopy Biosciences has made 2 acquisitions, including Core Diagnostics, and ZELLKRAFTWERK.
Who are Canopy Biosciences's investors?
Canopy Biosciences has 8 investors. Key investors include Bruker, Ampersand Capital Partners, Kingdom Capital, Missouri Technology, and Pinpoint Holdings.